Klein, Gernot
Petrone, Marcella
Yang, Ye
Hoang, Thuong
Hazlett, Sheila
Hansen, Lars
Flor, Armando
Funding for this research was provided by:
AstraZeneca
Article History
Accepted: 13 March 2023
First Online: 4 May 2023
Declarations
:
: This study was funded by AstraZeneca.
: Gernot Klein has no conflicts of interest to declare. Marcella Petrone, Ye Yang, Sheila Hazlett, Lars Hansen, and Armando Flor are employees and stockholders of AstraZeneca. Thuong Hoang is a stockholder of AstraZeneca.
: GK, MP, YY, TH, LH and AF conceived and designed the study; GK, TH, SH and AF collected the data; MP, YY, TH, LH and AF analyzed the data; MP carried out the PK analysis; and SH and AF supervised the project. All authors contributed to writing of the manuscript and approved the final manuscript for submission.
: This study was conducted in accordance with the principles of the Declaration of Helsinki, the International Council for Harmonisation Guidance for Good Clinical Practice, and with any applicable laws and conditions required by relevant regulatory authorities. The study protocol and informed consent documents were approved by the relevant Independent Ethics Committee of the Technical University of Munich.
: All participants provided written informed consent before study entry.
: Data underlying the findings described in this article may be obtained in accordance with AstraZeneca’s data sharing policy described at ExternalRef removed.